Войдите в систему

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.

The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by binding to the same receptor. This prevents the agonist drug from activating the receptor and producing its intended effect. For example, naloxone, a competitive antagonist, can block the effects of opioid drugs by binding to opioid receptors and reversing their activation.

In addition, functional or physiological antagonism occurs when a drug binds to a different receptor and produces a physiological response that opposes the effect of the agonist-bound receptor. For example, histamine stimulates acid secretion, while omeprazole prevents acid secretion by inhibiting the proton pump. These drugs can be considered functional antagonists.

Some drugs follow chemical antagonism, which involves the combination of two drugs to form an inactive product. Examples include chelating agents like dimercaprol, which bind to heavy metals and reduce their toxicity. The neutralizing antibody infliximab, which sequesters the inflammatory cytokine tumor necrosis factor (TNF), has an anti-inflammatory effect.

Antagonism can also occur through pharmacokinetic interactions, where one drug affects another drug's absorption, distribution, metabolism, or elimination. For instance, if a drug increases the metabolism or elimination of another drug, it can decrease the concentration and effectiveness of the second drug, leading to antagonistic effects.

Теги
AntagonismDrug InteractionReceptor BindingAllosteric ModulationFunctional InteractionChemical ReactionsPharmacokinetic ProcessesReceptor AntagonismCompetitive AntagonistOpioid ReceptorsPhysiological AntagonismChelating AgentsInfliximabTumor Necrosis Factor TNFDrug Metabolism

Из главы 4:

article

Now Playing

4.14 : Combined Effects of Drugs: Antagonism

Pharmacodynamics

7.5K Просмотры

article

4.1 : Принципы действия препарата

Pharmacodynamics

5.5K Просмотры

article

4.2 : Целевые показатели для действий с применением лекарственных средств: обзор

Pharmacodynamics

5.2K Просмотры

article

4.3 : Передача сигналов: обзор

Pharmacodynamics

8.0K Просмотры

article

4.4 : Механизм преобразователя: рецепторы, сопряженные с G-белком

Pharmacodynamics

1.7K Просмотры

article

4.5 : Лиганд-зависимый рецептор ионного канала: механизм стробирования

Pharmacodynamics

2.0K Просмотры

article

4.6 : Механизм преобразователя: фермент-сцепленные рецепторы

Pharmacodynamics

2.2K Просмотры

article

4.7 : Механизм преобразователя: ядерные рецепторы

Pharmacodynamics

1.2K Просмотры

article

4.8 : Зависимость «доза-реакция»: обзор

Pharmacodynamics

2.7K Просмотры

article

4.9 : Зависимость доза-реакция: активность и эффективность

Pharmacodynamics

4.0K Просмотры

article

4.10 : Зависимость доза-реакция: селективность и специфичность

Pharmacodynamics

6.1K Просмотры

article

4.11 : Терапевтический индекс

Pharmacodynamics

3.9K Просмотры

article

4.12 : Лекарственно-рецепторное взаимодействие: агонист

Pharmacodynamics

2.2K Просмотры

article

4.13 : Лекарственно-рецепторное взаимодействие: антагонист

Pharmacodynamics

2.4K Просмотры

article

4.15 : Комбинированное действие лекарственных препаратов: синергизм

Pharmacodynamics

3.1K Просмотры

See More

JoVE Logo

Исследования

Образование

О JoVE

Авторские права © 2025 MyJoVE Corporation. Все права защищены